daliresphcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Sitemap: https://www.daliresphcp.com/sitemap.xml Disallow: /etc/tags Disallow: /content/campaigns Disallow: | ||
Meta Tags
| Title | Exacerbation Treatment for Severe COPD | DALIRESP®(roflumilast) | For |
| Description | IMPORTANT SAFETY Learn about DALIRESP for patients with severe COPD associated with chronic bronchitis and a history of |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 13.225.223.7 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
daliresphcp.com Valuation
|
US$4,579,567
Last updated: 2023-05-14 12:21:58
daliresphcp.com has Semrush global rank of 2,311,202. daliresphcp.com has an estimated worth of US$ 4,579,567, based on its estimated Ads revenue. daliresphcp.com receives approximately 528,412 unique visitors each day. Its web server is located in United States, with IP address 13.225.223.7. According to SiteAdvisor, daliresphcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$4,579,567 |
| Daily Ads Revenue | US$4,228 |
| Monthly Ads Revenue | US$126,819 |
| Yearly Ads Revenue | US$1,521,826 |
| Daily Unique Visitors | 35,228 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| daliresphcp.com. | A | 299 | IP: 13.225.223.7 |
| daliresphcp.com. | A | 299 | IP: 13.225.223.96 |
| daliresphcp.com. | A | 299 | IP: 13.225.223.29 |
| daliresphcp.com. | A | 299 | IP: 13.225.223.124 |
| daliresphcp.com. | NS | 86400 | NS Record: ns-1977.awsdns-55.co.uk. |
| daliresphcp.com. | NS | 86400 | NS Record: ns-410.awsdns-51.com. |
| daliresphcp.com. | NS | 86400 | NS Record: ns-963.awsdns-56.net. |
| daliresphcp.com. | NS | 86400 | NS Record: ns-1189.awsdns-20.org. |
| daliresphcp.com. | MX | 1800 | MX Record: 10 mxa-0015e701.gslb.pphosted.com. |
| daliresphcp.com. | MX | 1800 | MX Record: 10 mxb-0015e701.gslb.pphosted.com. |
| daliresphcp.com. | TXT | 14400 | TXT Record: v=spf1 mx include:spf-0015e701.pphosted.com ~all |
HtmlToTextCheckTime:2023-05-14 12:21:58
| Exacerbation Treatment for Severe COPD | DALIRESP®(roflumilast) | For HCPs Error 404 Search Results | DALIRESP® (roflumilast) Health Care Professional Site Important Safety Information | DALIRESP® (roflumilast) | For HCPs Contact US | DALIRESP®(roflumilast) | For HCPs DALIRESP® (roflumilast) Dosing | For HCPs DALIRESP®(roflumilast) Efficacy | For HCPs Safety and Adverse Reactions | DALIRESP®(roflumilast) | For HCPs DALIRESP® (roflumilast) Mechanism of Action | For HCPs Sitemap for HCPs | DALIRESP®(roflumilast) | For HCPs print_label | resize_label Registration Successful... null you have successfully logged registered and logged in Go For US Health Care Professionals Visit Patient Site | AZ Medical Information Support Important Safety Information | Indication | Prescribing Information | Medication Guide MENU CLOSE MENU HOME EFFICACY DOSING SAFETY MECHANISM OF ACTION PATIENT SAVINGS OFFER --> To reduce the risk of COPD exacerbations in patients with severe COPD associated with |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Type: text/html; charset=iso-8859-1 Connection: keep-alive Cache-Control: max-age=172800 Cache-Control: no-cache="set-cookie" Date: Thu, 23 Dec 2021 09:59:41 GMT Expires: Sat, 25 Dec 2021 09:59:41 GMT Location: https://www.daliresphcp.com/ Server: astrazeneca.com Communique/4.3.3 Set-Cookie: AWSELB=0115356D0650D38585E26AA515145E3CC9AE6808A1CA7A891E03EA80BA7180318C89AEFA25EA8CFED491350F1E7DFD1CEEC24AE2B7A93FD018604DEEA1B29CF6CEFDD3EFBA;PATH=/;MAX-AGE=900 X-Cache: Miss from cloudfront Via: 1.1 a3974a97ba504b481cfb8868c9d58588.cloudfront.net (CloudFront) X-Amz-Cf-Pop: JFK51-C1 X-Amz-Cf-Id: HiINVF4EKLFjqT902U9nOd0cL_xKX6dRHJjbQQ8AMtW4OP5L_NlPLw== HTTP/1.1 200 OK Content-Type: text/html;charset=utf-8 Connection: keep-alive Access-Control-Allow-Origin: https://policy.cookiereports.com Cache-Control: no-cache="set-cookie" Date: Thu, 23 Dec 2021 09:59:41 GMT Expires: Thu, 01 Jan 1970 00:00:00 GMT Server: astrazeneca.com Communique/4.3.3 Set-Cookie: hasVisitedLandingPage=yes; Path=/;HttpOnly;Secure Set-Cookie: keepMeSignedIn=yes; Path=/;HttpOnly;Secure Set-Cookie: AWSELB=0115356D0650D38585E26AA515145E3CC9AE6808A1391A8E899EE3DF7278C1FB87515C524CEA8CFED491350F1E7DFD1CEEC24AE2B7A190F515091D14E9F8FAF17B051BDA5B;PATH=/;MAX-AGE=900 Set-Cookie: AWSELBCORS=0115356D0650D38585E26AA515145E3CC9AE6808A1391A8E899EE3DF7278C1FB87515C524CEA8CFED491350F1E7DFD1CEEC24AE2B7A190F515091D14E9F8FAF17B051BDA5B;PATH=/;MAX-AGE=900;SECURE;SAMESITE=None X-Content-Type-Options: nosniff X-Frame-Options: SAMEORIGIN X-Powered-By: Jetty(9.4.26.v20200117) Vary: User-Agent X-Cache: Miss from cloudfront Via: 1.1 7787c17f7e39468ee68e2078b8b5894e.cloudfront.net (CloudFront) X-Amz-Cf-Pop: JFK51-C1 X-Amz-Cf-Id: 0-reZRUoNbKVMdCR4P0PmfajH0h11Mgr-1WELeUklIMcGk4RSkoCsA== |
daliresphcp.com Whois Information
Domain Name: DALIRESPHCP.COM Registry Domain ID: 1681659786_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-08-30T16:35:28Z Creation Date: 2011-10-11T21:09:36Z Registry Expiry Date: 2022-10-11T21:09:36Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1189.AWSDNS-20.ORG Name Server: NS-1977.AWSDNS-55.CO.UK Name Server: NS-410.AWSDNS-51.COM Name Server: NS-963.AWSDNS-56.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-26T07:46:51Z <<< |